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INTRODUCTION: The surgical technique for esophagectomy to treat esophageal malignancies has been
improved over the past several decades. Nevertheless, it remains extremely difﬁcult to surgically treat
patients with locally advanced T4b tumors invading the aorta or respiratory tract.
PRESENTAION OF CASE: A 37-year-old Japanese man was diagnosed with T4b (descending aorta) N2M0,
Stage IIIC middle thoracic esophageal squamous cell carcinoma. He was initially treated with deﬁnitive
CRT followed by 3 courses of DCF. After theDCF, CT showed that themain tumor had shrunk and appeared
to have separated from the descending aorta. Thereforewe decided to perform a salvage esophagectomy.
Because we needed the ability to closely observe the site of invasion to determine whether aortic inva-
sion was still present, half the esophageal resection was performed under right thoracotomy, but the
ﬁnal resection at the invasion site was performed under left thoracotomy. Consequently, the thoracic
esophagus was safely removed and aortic replacement was avoided. The patient has now survived more
than 30 months after the salvage esophagectomy with no additional treatment for esophageal cancer
and no evidence of recurrent disease.
DISCUSSION: Because this and the previously reported procedures, each have particular advantages and
disadvantages, one must contemplate and select an approach based on the situation for each individual
patient.
CONCLUSION: Salvage esophagectomy through a right thoracotomy followed by careful observation of
the invasion site for possible aortic replacement through a left thoracotomy is an optional procedure for
these patients.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The surgical technique for esophagectomy to treat esophageal
malignancies has been greatly improved over the past several
decades [1,2]. Nevertheless, it remains extremely difﬁcult to sur-
gically treat patients with locally advanced tumors invading the
aorta or respiratory tract. The exclusive treatment strategy for
these patients is deﬁnitive chemoradiotherapy (CRT), and some
good responders achieve clinically complete response (CR), as
evaluated using esophagography, CT, FDG-PET and/or biopsy after
upper gastrointestinal endoscopy [3]. Unfortunately, the incidence
of locoregional recurrence is quite high, even among clinical CR
patients [4–6]. Because the diagnostic tools available are not suf-
Abbreviations: CRT, chemoradiotherapy; DCF, docetaxel plus 5-ﬂuorouracil
and cisplatin; PET-CT, positron emission tomography-computed tomography; SUV,
standardized uptake volume.
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ﬁcient to ensure microscopic extinction of viable cancer cells in
submucosal scar tissue, salvage esophagectomy appears to be the
sole curative treatment option for thesepatients [4]. This procedure
is associated with high morbidity and mortality, but if it is per-
formed safely, it has the potential to provide cancer free long-term
survival for these patients [4].
The following case report describes the therapeutic course of
a patient diagnosed with advanced thoracic esophageal squamous
cell carcinoma invading the descending aorta. This is theﬁrst report
of a salvage esophagectomy through a right thoracotomy followed
byobservationof theaortic invasion site througha left thoracotomy
in a patient with T4b locally advanced esophageal squamous cell
carcinoma.
2. Case presentation
A 37-year-old Japanesemanwas seen in a clinic because of pro-
gressive dysphagia. He was diagnosed with thoracic esophageal
squamous cell carcinoma, based on esophagogastroscopy, and was
then referred to our department for further management. He had
http://dx.doi.org/10.1016/j.ijscr.2015.01.018
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Findings on examination: (A) Esophagogastroscopy showing a nearly circumferential type 3 tumor 25 cm from the incisors. (B) Histological examination of a biopsy
specimen showed well-differentiated squamous cell carcinoma. (C) Barium contrast esophagography revealed a 10 cm-long tumor mainly in the middle of the esophagus.
a past medical history of hospital treatments for alcohol depen-
dence, and his father passed away from esophageal cancer while
he was in his 40s. Esophagogastroscopy showed the presence of
a nearly circumferential type 3 tumor 25 cm from the incisors
(Fig. 1A). Histological examination of a biopsy specimen showed
well-differentiated squamous cell carcinoma (Fig. 1B). Barium
contrast esophagography revealed a ∼10 cm-long tumor situated
mainly in the middle of the esophagus (Fig. 1C). In addition, com-
puted tomography revealed that the main tumor had invaded the
descending aorta (Fig. 2A) and that lymphnodes in the uppermedi-
astinum were enlarged. 18F-ﬂuorodeoxy glucose PET-CT identiﬁed
a tumorwith a SUVmax of 19.5 (Fig. 2B). Based on these results, this
patient was diagnosed with T4b (descending aorta) N2M0, Stage
IIIC middle thoracic esophageal squamous cell carcinoma.
Thepatientwas initially treatedwithdeﬁnitive CRT: 61.2Gy and
2 courses of cisplatin plus 5-ﬂuorouracil [7,8]. After the CRT, the
main tumor and lymph node metastasis were reduced, which was
deemed a partial response. However, CT and PET-CT ﬁndings indi-
cated that the main tumor was still invading the descending aorta.
Therefore, 3 courses of docetaxel plus 5-ﬂuorouracil and cisplatin
(DCF) were then administrated [9].
After the DCF, CT showed that the main tumor had shrunk and
appeared to have separated from the descending aorta (Fig. 3A).
Moreover, the enlarged lymph nodes in the upper mediastinum
were still reduced and no other lymph nodes showed enlargement.
On the other hand, barium contrast esophagography revealed that
there was a deep ulcer on left dorsal wall of middle esophagus
(Fig. 3B). Upper gastrointestinal endoscopy also showed the ulcer,
and there was no evidence of residual cancer cells, even in biopsy
specimens (Fig. 3C). Based on these results, and after much con-
sultation with the patient and his family, we decided to perform a
salvage esophagectomy.
In performing this salvage esophagectomy, the following issues
had to be addressed. We needed the ability to closely observe
the site of invasion to determine whether aortic invasion was still
present. Therefore, half the esophageal resection was performed
under right thoracotomy, but the ﬁnal resection at the invasion
site was performed under left thoracotomy. In addition, we pre-
Fig. 2. Pretreatment imaging ﬁndings: (A) CT showing themain tumor and suggest-
ing direct invasion of the descending aorta. (B) FDG-PET showing a SUVmax of 19.5
in the main tumor.
pared an extracorporeal circulation system with administration of
heparin for the possible aortic replacement and monitored motor
evoked potentials (MEPs) to detect spinal cord infarction.
Twelvemonths after beginning the initial deﬁnitive CRT, the sal-
vage esophagectomywith bilateral thoracotomywas performed. A
CASE REPORT – OPEN ACCESS
78 Y. Nagaki et al. / International Journal of Surgery Case Reports 8 (2015) 76–80
Fig. 3. Post treatment CT imaging ﬁndings: (A) After CRT and DCF, the main tumor had shrunk and appeared to be separated from the descending aorta. (B) Barium contrast
esophagography revealed a deep ulcer on the left dorsal wall of the middle esophagus. (C) Upper gastrointestinal endoscopy showing the ulcer. There was no evidence of
residual cancer cells in biopsy specimens.
single-lumen spiral tracheal tube with bronchial blocker was used
for one-lung ventilation. Initially, the chest was opened through
a right posterolateral incision in the ﬁfth intercostal space with
the patient in the left decubitus position. After thoracic esophageal
separation andupper-to-lowermediastinal lymphnode dissection,
esophageal transectionswere done at the aortic arch and diaphrag-
matic levels using a curved cutter stapler (Ethicon, NJ). Detachment
of the main tumor from the descending aorta was not done in this
operative ﬁeld. After closing the right thoracicwall, the patientwas
moved to the right decubitus position, and the chest was opened
through a left posterolateral incision in the ﬁfth intercostal space.
The descending aorta was encircled with tape at the proximal and
distal sites of the main tumor. Within this operative ﬁeld, we were
able to observe the invasion site directly (Fig. 4). Because the area
of the invasion site was difﬁcult to separate with blunt dissection
andwas smaller than expected, we determined it could be resected
using sharpdissection. Sharpdissection of hard scar tissuewith for-
ceps was done with meticulous care, and the thoracic esophagus
was safely removed. Intraoperative histopathological investigation
revealed that there was only scar tissue and no esophageal can-
cer cells in the resected margin. Therefore, aortic replacement and
administration of heparin were not needed. After closing the left
thoracic wall, the patient was moved to a supine position. Abdom-
inal lymph node dissection and construction of the gastric conduit
was then done concomitantly with bilateral neck lymph node dis-
section. The gastric conduit was pulled up to the left neck via
the subcutaneous route, and esophago-gastric conduit anastomosis
was accomplished through layer-to-layer hand sewing. Finally, an
8 Fr feeding tube was inserted through anterior wall of the gastric
conduit into the jejunum. The operation time was 11h 43min, and
the blood loss was 289g with no blood transfusion.
Following the salvage esophagectomy, the patient stayed in the
ICU for 5 days. Tube feeding was started on POD 3 and oral intake
was started on POD 9. Temporal left recurrent nerve paralysis was
seen but improved gradually during the patient’s hospital stay.
Because the patient developed central venous catheter fever, his
hospital stay after the salvage esophagectomy was 60 days.
Final histopathological diagnosis was pT1(pTis), ly0, v0, pN0,
pStage0 with CRT efﬁciency grade 2. Residual cancer tissue was
observed only in the epithelium of themain tumor site (Fig. 5). The
patient has now survived more than 30 months after the salvage
esophagectomywithnoadditional treatment for esophageal cancer
and no evidence of recurrent disease.
3. Discussion
Several attempts to surgically treat patients with T4b locally
advanced tumors invading the descending aorta have been
reported previously. Cong et al. reported on 47 patients with
esophageal carcinoma invading the descending aorta who under-
went radical esophagectomy combined with off-pump aortic
replacement through a left thoracotomy [10]. Among these
patients, only 5 [10.6%] received preoperative CRT. Although all 47
patients showed acceptable long-term overall survival, complica-
tions were observed in 28 patients [59.6%], including one patient
with aorta-graft anastomotic bleeding. Moreover, there is a high
likelihood that this procedure would have a higher complication
rate following deﬁnitive CRT. It is also difﬁcult to perform upper
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Fig. 4. A Frame format of surgical ﬁeld: Through the left thoracotomy, wewere able
to observe the aortic invasion site directly. Because the area of the invasion site was
difﬁcult to separate using blunt dissection and was smaller than expected, it was
our evaluation that the invasion site could be resectedwith sharp dissectionwithout
aortic replacement.
mediastinal lymph node dissection using only a left thoracotomy
due to the position of the aortic arch.
Kabuto et al. performed resection of the aortic wall using
a temporary aorta-aorta bypass in combination with a radical
Fig. 5. Final histopathological diagnosis: pT1(pTis), ly0, v0, pN0, pStage0 with CRT
efﬁciency grade 2. Residual cancer tissue was observed only in epithelium of the
main tumor site.
esophagectomy through a right thoracotomy in 4 patients [11].
These 4 patients achieved longer survival times without particular
complications after the surgery.However, they toohadnot received
any preoperative treatment. In addition, the view through a right
thoracotomy makes it difﬁcult to observe the aortic invasion site
because it is on the opposite site of the esophageal cancer. What’s
more, a right thoracotomy also makes it difﬁcult to observe the
descendingaorta inpatientswhere it tends tobebehindofvertebral
column.
Kawahara et al. reported a 2-stage operation consisting of aortic
replacement through a left thoracic approach, followed by radical
esophagectomy through a right thoracic approach [12]. This proce-
dure has the beneﬁt that surgeons are able to closely observe the
invasion site at the beginning of the surgery. In cases where aortic
replacement is inevitable, radical esophagectomywith lymphnode
dissection through a right thoracic approach should be performed
after the aortic replacement and administration of heparin.
In the present case, we performed the opposite procedure: rad-
ical esophagectomy through the right thoracotomy followed by
observation of the aortic invasion site through a left thoracotomy.
Fortunately,with careful observation through the left thoracotomy,
aortic replacement was avoided and curative salvage esophagec-
tomy was accomplished. Because this and the previously reported
procedures each have particular advantages and disadvantages,
one must contemplate and select an approach based on the sit-
uation for each individual patient.
4. Conclusion
Salvage esophagectomy through a right thoracotomy followed
by careful observation of the invasion site for possible aortic
replacement through a left thoracotomy is an optional procedure
for these patients.
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